JP2003513933A - 喘息治療用インターフェロンガンマ - Google Patents

喘息治療用インターフェロンガンマ

Info

Publication number
JP2003513933A
JP2003513933A JP2001536177A JP2001536177A JP2003513933A JP 2003513933 A JP2003513933 A JP 2003513933A JP 2001536177 A JP2001536177 A JP 2001536177A JP 2001536177 A JP2001536177 A JP 2001536177A JP 2003513933 A JP2003513933 A JP 2003513933A
Authority
JP
Japan
Prior art keywords
ifn
glucocorticoid
administered
dose
asthma
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2001536177A
Other languages
English (en)
Japanese (ja)
Inventor
ルッツ−ヘンニング・ブロック
ロルフ・ツィーシェ
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
MONDOBIOTECH SA
Original Assignee
MONDOBIOTECH SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by MONDOBIOTECH SA filed Critical MONDOBIOTECH SA
Publication of JP2003513933A publication Critical patent/JP2003513933A/ja
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A61K38/217—IFN-gamma
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pulmonology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Rheumatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pain & Pain Management (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
JP2001536177A 1999-11-10 2000-11-06 喘息治療用インターフェロンガンマ Pending JP2003513933A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP99122357 1999-11-10
EP99122357.9 1999-11-10
PCT/EP2000/010941 WO2001034180A2 (fr) 1999-11-10 2000-11-06 Interferon gamma pour le traitement de l'asthme

Publications (1)

Publication Number Publication Date
JP2003513933A true JP2003513933A (ja) 2003-04-15

Family

ID=8239362

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2001536177A Pending JP2003513933A (ja) 1999-11-10 2000-11-06 喘息治療用インターフェロンガンマ

Country Status (5)

Country Link
EP (1) EP1227831A2 (fr)
JP (1) JP2003513933A (fr)
AU (1) AU1392301A (fr)
CA (1) CA2387089A1 (fr)
WO (1) WO2001034180A2 (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPR381601A0 (en) * 2001-03-19 2001-04-12 Monash University Method of treating respiratory conditions
US6911198B2 (en) 2001-09-17 2005-06-28 Yeda Research And Development Co. Ltd. Method and pharmaceutical composition for treating inflammation
WO2003051388A2 (fr) * 2001-12-18 2003-06-26 Mondobiotech Laboratories Anstalt Nouvelle composition pharmaceutique d'interferon gamma ou de pirfenidone associe a des agents moleculaires diagnostiques permettant un traitement ameliore des affections pulmonaires interstitielles
EP1430902A1 (fr) * 2002-12-20 2004-06-23 Mondobiotech Laboratories Anstalt Composition pharmaceutique comprenant l'interferon gamma avec diagnostic moléculaire pour un meilleur traitment de l'asthme
US20070031377A1 (en) * 2003-03-28 2007-02-08 Stany Depraetere Treatment of type 1 immune response-mediated inflammatory lung disease by modulation of ifn-gamma activity
EP1516627A1 (fr) * 2003-09-17 2005-03-23 CONARIS research institute AG Interferon-gamma pour le traitement de maladies associées au gène NOD2
US11135223B2 (en) 2016-01-22 2021-10-05 Yale University Compositions and methods for inhibiting Dkk-1

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL76591A0 (en) * 1984-10-05 1986-02-28 Bioferon Biochem Substanz Pharmaceutical compositions containing ifn-ypsilon and processes for the preparation thereof
EP0311616B1 (fr) * 1986-06-17 1991-09-25 Biogen, Inc. Combinaisons d'interferons gamma et d'agents anti-inflammatoires ou anti-pyretiques pour le traitement de maladies
DK0502997T3 (da) * 1989-12-01 1995-07-17 Childrens Medical Center Behandling af atopiske sygdomme med gamma-interferon
EP0795332B1 (fr) * 1996-03-14 2005-06-01 Mondobiotech Interferon SA Utilisation médicale de gamma interféron dans les maladies pulmonaires interstitielles

Also Published As

Publication number Publication date
EP1227831A2 (fr) 2002-08-07
AU1392301A (en) 2001-06-06
CA2387089A1 (fr) 2001-05-17
WO2001034180A3 (fr) 2001-11-08
WO2001034180A2 (fr) 2001-05-17

Similar Documents

Publication Publication Date Title
CN115605508A (zh) 用于治疗冠状病毒感染和所产生的炎症诱导的肺损伤的方法
JP2001513106A (ja) グルココルチコイドと局所麻酔剤との相乗的な併用による好酸球関連病態、例えば気管支喘息の治療
EP2442832B1 (fr) Compositions et procédés pour le traitement de la sclérose en plaques
EP3308835B1 (fr) Utilisation de lévocétirizine et de montélukast dans le traitement des blessures traumatiques
WO2012096411A1 (fr) Méthode de prévention ou traitement de maladie intestinale inflammatoire réfractaire
KR20090114341A (ko) Ｆｇｆ2를 유효성분으로 포함하는 천식 및 만성폐쇄성 폐질환 예방 또는 치료제
JP2003513933A (ja) 喘息治療用インターフェロンガンマ
KR20150011379A (ko) 옥시부티닌 투여를 위한 방법 및 조성물
US6096721A (en) Method for treating mucositis by sublingual administration of DNA
EP0795332B1 (fr) Utilisation médicale de gamma interféron dans les maladies pulmonaires interstitielles
CA2323213C (fr) Traitement des maladies respiratoires et de l'otite moyenne
US20230165870A1 (en) 6,8-dioxa-3-azabicyclo[3.2.l]Octane Carboxylic Acids And Their Derivatives For Use In The Treatment Of Inflammations
AU2010270425B2 (en) Use of benzydamine in the treatment of p40-dependent diseases
JP2003532682A (ja) 血管新生の治療のための方法および組成物
JP2002220343A (ja) びまん性肺疾患延命剤
JP4023863B2 (ja) Ｉｌ−６を含む血清尿酸値低下剤
JP2759050B2 (ja) 突発性難聴治療用医薬組成物
US20220387475A1 (en) Methods and compositions for treating endometriosis
CN109939223B (zh) 一种白介素2在制备用于治疗寻常型天疱疮口腔糜烂药物的应用
WO2023220396A1 (fr) Procédés de traitement utilisant un inhibiteur de kinase 1a à double spécificité régulée par la phosphorylation de la tyrosine (dyrk1a)
JPH10273448A (ja) アトピー性疾患治療のための口腔内投与用治療薬
Niven et al. Bronchial thermoplasty in refractory asthma: Interim results in a severe asthma population (Research in Severe Asthma (RISA) Trial)
Martin-Orozco et al. Immunostimulatory DNA Sequences Inhibit
JPH03291237A (ja) アレルギー性疾患治療用医薬組成物
JP2001500125A (ja) コレステロールレベルを低下させるための方法